Analysis of epidermal growth factor ('25J-
INTRODUCTION
Binding sites for the epidermal growth factor (EGF) have been described for a great variety of different cell types (for a review see [l] ). Specific binding to plasma cell membranes is thought to be due to interaction of the growth factor with its receptor, a 170 kDa membrane protein whose structure has been studied in great detail especially in A 43 1 cells [ 11. The extracellular portion of the EGF receptor contains several oligosaccharide chains which, at least in the case of A 431 cells, has been shown to contain terminal blood group A antigen-like sugar residues [2, 3] . A recent study indicates that modification of these terminal sugar residues may alter both interaction of EGF with its high affinity binding site as well as the kinase activity of the receptor [4] .
The detection of the presence of binding sites for EGF on human erythrocytes (see Results) prompted us to investigate the ABO-blood group dependence of EGF binding to these cells. Several human red cell membrane proteins and membrane lipids are known to bear oligosaccharide chains with ABH-antigen-like properties [5] . We hypothesized that, in analogy to the EGF receptor of A 43 1 cells, the putative EGF receptor of human erythrocytes might well be equipped with ABH-antigen-like sugar residues. Since erythrocytes with different ABHantigens are believed to differ only in the composition of the protein and lipid attached sugar chains, donors with 0 1992 Wiley-Liss, Inc.
different ABO-blood groups may serve as "biological variants" for the study of the influence of ABH-antigens on binding of EGF to these cells.
MATERIALS AND METHODS
Venous blood anticoagulated by heparin was drawn from apparently healthy donors. Red cells were washed four times with 10 vol of a solution containing 140 mM NaCl, 5 mM KCl, 5 mM glycylglycine, 5 mM glucose, 0.2 mM MgCl,, 1.25 mM CaC1, (pH 7 . 5 9 , referred to as Na buffer throughout.
Cells were counted under a light microscope (Neubauer chamber); 50 (~.l of packed red cells were incubated (in triplicates) for 3 hr at 4°C with 12 concentrations of '251-EGF (Amersham-Buchler, Braunschweig, Germany, specific activity 0.76 Ciimmol) in the range between 1 .0 X lOW9-2 X M, the total reaction volume amounting to 500 ~1 .
The reaction was started by manual addition of the red cell suspension and stopped by centrifugation for 10 min at 10,000g in an Eppendorf-Hermle centrifuge Model Z 380 (Eppendorf, Hamburg, Germany). Cells were quickly washed three times at 4°C with ice-cold Na buffer. Radioactivity of the pellets (total binding) was assessed by gamma-counting. Unspecific binding as determined in the presence of an excess of unlabelled EGF (1.6 X M) was found to be less than 30% of total binding for both types of binding sites. Pipetting was performed by a Tecan Robotic Sample processor Model 5052 (dual arm system, Tecan AG, Frankfurt, Germany) as described in [6] . For all experiments given in Results the following binding equation for two independent classes of binding sites [7] was fitted to the data by nonlinear regression analysis yielding estimates of the binding parameters for a high-and a lowaffinity binding site.
where B,,, , K,, are the high-affinity binding site parameters, Bm2, K,, are the low-affinity binding site parameters, cf, ch are free and bound concentration of ligand, and C is the constant (correcting for unspecific binding). The above equation gives an estimate of the specific binding of a ligand to two independent binding sites (first two terms on the right side of the equation). The constant C is used to correct for any linear portion of total binding (indicative of unspecific binding) remaining after fitting the data to the parameters for two saturating binding curves.
RESULTS
Nonlinear regression analysis revealed the presence of two types of binding sites for the epidermal growth factor (EGF) on human erythrocytes (Fig. 1) : a high-affinity binding site with an apparent equilibrium dissociation constant in the 10-lo-lO-y M range (0.2-4.3 X lo-' M) and about 1,000 sitedcell (58&2,400) and a low-affinity binding site with an apparent equilibrium dissociation constant in the lo-' M range (1.8-5.7 X lo-' M) and around 10,000 sitedcell (7,20@23,000) .
No considerable differences in app. K, values were observed between donors with different ABO-blood groups for both types of binding sites. A, erythrocytes exhibited a higher number of binding sites for EGF as compared to red cells taken from individuals with blood groups 0 and B (Tab. I), the increase being more prominent for the high affinity binding site (Tab. I).
DISCUSSION
The results of the present study indicate that human red cells bear two (hitherto unknown) classes of independent binding sites for epidermal growth factor (EGF), in ac- cordance with results obtained on several other cell types [I] . A recent report indicates that the most abundant membrane protein present in human erythrocytes, the band 3 protein, is a fairly good substrate for the EGF receptor associated tyrosine kinase [8]. In addition, we observed in human erythrocytes a Ca inward transport susceptible towards inhibition by the phorbol ester TPA [9] . Thus, there is both direct and indirect evidence that EGF elicits intracellular responses in human erythrocytes. The EGF receptor of A 431 cells has been shown to bear ABH-blood group antigen-like sugar structures [2, 3] which may influence binding of the growth factor to its receptor [4] . In the study of Defize et al. [4] , the lack of blood group antigen A on A43 1 cells was associated with an increased number of high affinity receptors for EGF. In contrast, in the present study, the amount of highaffinity binding sites for EGF on human erythrocytes was higher in blood group A, as compared to blood group B and 0 erythrocytes (Table I) . However, observations re- [2, 10] . However, these cell types (fibroblasts, Swiss 3T3 cells, and human placenta) are not known to contain ABHantigen-like sugar structures on the proteins of their plasma membranes. In contrast, human erythrocytes are well known to bear these oligosaccharides on membrane proteins [ 5 ] . The preliminary data presented in Table I indicate that in erythrocytes of blood group A, donors higher number of EGF binding sites are present. The simplest explanation of these results would be that the different ABH-antigens present on a hitherto not demonstrated EGF receptor of human erythrocytes might influence the binding of EGF. Alternatively, ABH antigens present on red cell glycoproteins or glycolipids in close vicinity to the EGF binding site could modulate the interaction of EGF with its binding site.
Since only a low number of donors have been analyzed in the present investigation, the results require confirmation from studies performed on larger populations. Furthermore, it should also be investigated in future studies whether human red cells contain EGF receptors similar to those of other cell types (e.g., by immunoprecipitation of the phosphorylated receptor). Such experiments will be of particular importance in view of previous observations indicating that cells of the human hematopoietic system do not appear to express the EGF receptor [ 11. Wilhelm Sander-Stiftung for financial support (grant 89.039.1 to U.S.).
